CompletedPhase 1NCT01139151

4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Hagop Kantarjian, MD
UT MD Anderson Cancer Center
Intervention
3 Day Thiarabine(drug)
Enrollment
31 enrolled
Eligibility
16 years · All sexes
Timeline
20102013

Study locations (1)

Collaborators

Access Pharmaceuticals, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01139151 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials